CD274 and neoplasm: Comparatively, the “cold” tumor is generally characterized by the lack of a sufficient release of tumor–associated antigens (TAAs) and a sparse infiltration with immune cells, particularly the CTLs, which hinders the clinical application of the PD–L1 inhibitors [8,9,10,11].